<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: clinical trials</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Novel experimental agent is highly active in CLL patients, interim study shows</title>
   	 <description>An interim analysis of a phase II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated both in patients who are undergoing treatment for the first time and those who have relapsed and are resistant to other therapy.</description>
     <link>http://medicalxpress.com/news/2011-06-experimental-agent-highly-cll-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 09:42:26 EST</pubDate>
	 <guid isPermaLink="false">news226572134</guid>
	 
</item>
<item>
     <title>Heat helps cancer drugs battle cancer</title>
   	 <description>(PhysOrg.com) -- Localized hyperthermia has been used occasionally with cancer drugs for some time, but until now, the reason it helps has been a mystery.  In a report in the Proceedings of the National Academy of Sciences, scientists have discovered that the addition of heat inhibits homologous recombination so the cancer cells are unable to repair DNA damage caused by the cancer treatments.</description>
     <link>http://medicalxpress.com/news/2011-05-cancer-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 10 May 2011 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news224255592</guid>
	 
</item>


</channel>
</rss>
